🇺🇸 FDA
Patent

US 8198304

Guanidine-containing compounds useful as muscarinic receptor antagonists

granted A61PA61P1/04A61P1/12

Quick answer

US patent 8198304 (Guanidine-containing compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P1/04, A61P1/12, A61P11/00, A61P11/02